$1.41
At close: Apr 24 EDT
$1.44
0.031.87%
Pre-Market: 8:05 AM EDT
Comments
Loading...
Cocrystal Pharma (COCP) Forecast
NewsEarningsCocrystal Pharma (COCP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Cocrystal Pharma Stock Price, Quotes and Forecasts | NASDAQ:COCP | Benzinga
Explore Cocrystal Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for COCP.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cocrystal Pharma (COCP) stock?
You can purchase shares of Cocrystal Pharma (NASDAQ:COCP) through any online brokerage.
Who are Cocrystal Pharma (COCP) competitors?
Other companies in Cocrystal Pharma’s space includes: Cingulate (NASDAQ:CING), Addex Therapeutics (NASDAQ:ADXN), Kiora Pharmaceuticals (NASDAQ:KPRX), CalciMedica (NASDAQ:CALC) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
What is the forecast, or price target, for Cocrystal Pharma (COCP) stock?
Cocrystal Pharma has a consensus price target of $7.00.
What is the current price for Cocrystal Pharma (COCP)?
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $1.44 last updated April 24, 2025 at 8:05 AM EDT.
Does Cocrystal Pharma (COCP) pay a dividend?
There are no upcoming dividends for Cocrystal Pharma.
When is Cocrystal Pharma (NASDAQ:COCP) reporting earnings?
Cocrystal Pharma’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Cocrystal Pharma (COCP) going to split?
There is no upcoming split for Cocrystal Pharma.
What sector and industry does Cocrystal Pharma (COCP) operate in?
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
